Living with MG means navigating a complex treatment journey. While we’ve come a long way with effective therapies like steroids, immunosuppressants, IVIG, and surgery, not all patients respond the same way. New treatments aim to fill these gaps, providing more options and hope for people with this challenging condition.

Whether you’re newly diagnosed or have been managing MG for years, understanding your options empowers you to have more informed conversations with your healthcare team.

The MAA thank the Medical Advisory Board Doctors – Dr Katherine Buzzard, A/Prof Stefan Blum and A/Prof Stephen Reddel – for sharing their knowledge once again and for supporting the Australian Myasthenia community.